These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30362507)

  • 1. Melanoma: Where we are and where we go.
    Mohammadpour A; Derakhshan M; Darabi H; Hedayat P; Momeni M
    J Cell Physiol; 2019 Apr; 234(4):3307-3320. PubMed ID: 30362507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Advances and Treatment Options in Metastatic Melanoma.
    Johnson DB; Sosman JA
    JAMA Oncol; 2015 Jun; 1(3):380-6. PubMed ID: 26181188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNAs as Key Players in the Management of Cutaneous Melanoma.
    Lorusso C; De Summa S; Pinto R; Danza K; Tommasi S
    Cells; 2020 Feb; 9(2):. PubMed ID: 32054078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic biomarkers in skin cancer.
    Greenberg ES; Chong KK; Huynh KT; Tanaka R; Hoon DS
    Cancer Lett; 2014 Jan; 342(2):170-7. PubMed ID: 22289720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers.
    Ross CL; Kaushik S; Valdes-Rodriguez R; Anvekar R
    J Cell Physiol; 2018 Jul; 233(7):5133-5141. PubMed ID: 29226953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers.
    Golabchi K; Soleimani-Jelodar R; Aghadoost N; Momeni F; Moridikia A; Nahand JS; Masoudifar A; Razmjoo H; Mirzaei H
    J Cell Physiol; 2018 Apr; 233(4):3016-3023. PubMed ID: 28657205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive detection of melanoma metastasis using circulating microRNA expression profiles.
    Shiiyama R; Fukushima S; Jinnin M; Yamashita J; Miyashita A; Nakahara S; Kogi A; Aoi J; Masuguchi S; Inoue Y; Ihn H
    Melanoma Res; 2013 Oct; 23(5):366-72. PubMed ID: 23863473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future of circulating tumor cells in the melanoma clinical and research laboratory settings.
    De Souza LM; Robertson BM; Robertson GP
    Cancer Lett; 2017 Apr; 392():60-70. PubMed ID: 28163189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma.
    Armand-Labit V; Meyer N; Casanova A; Bonnabau H; Platzer V; Tournier E; Sansas B; Verdun S; Thouvenot B; Hilselberger B; Doncescu A; Lamant L; Lacroix-Triki M; Favre G; Pradines A
    Acta Derm Venereol; 2016 Jan; 96(1):29-34. PubMed ID: 26039581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in malignant melanoma.
    Völler D; Ott C; Bosserhoff A
    Clin Biochem; 2013 Jul; 46(10-11):909-17. PubMed ID: 23360785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma.
    Khoja L; Lorigan P; Zhou C; Lancashire M; Booth J; Cummings J; Califano R; Clack G; Hughes A; Dive C
    J Invest Dermatol; 2013 Jun; 133(6):1582-90. PubMed ID: 23223143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of microRNAs in melanoma.
    Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
    Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.
    Aftab MN; Dinger ME; Perera RJ
    Arch Biochem Biophys; 2014 Dec; 563():60-70. PubMed ID: 25065585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of miR-203 is decreased and associated with the prognosis of melanoma patients.
    Wang K; Zhang ZW
    Int J Clin Exp Pathol; 2015; 8(10):13249-54. PubMed ID: 26722525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis.
    Lohcharoenkal W; Das Mahapatra K; Pasquali L; Crudden C; Kular L; Akkaya Ulum YZ; Zhang L; Xu Landén N; Girnita L; Jagodic M; Ståhle M; Sonkoly E; Pivarcsi A
    J Invest Dermatol; 2018 Apr; 138(4):882-892. PubMed ID: 29104160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Biomarkers in Cutaneous Melanoma.
    Eisenstein A; Gonzalez EC; Raghunathan R; Xu X; Wu M; McLean EO; McGee J; Ryu B; Alani RM
    Mol Diagn Ther; 2018 Apr; 22(2):203-218. PubMed ID: 29411301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.
    Leibowitz-Amit R; Sidi Y; Avni D
    Pigment Cell Melanoma Res; 2012 Nov; 25(6):740-57. PubMed ID: 22958787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs role as potential biomarkers and key regulators in melanoma.
    Varamo C; Occelli M; Vivenza D; Merlano M; Lo Nigro C
    Genes Chromosomes Cancer; 2017 Jan; 56(1):3-10. PubMed ID: 27561079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling in melanoma: past results and future potential.
    Knackstedt RW; Knackstedt T; Gastman B
    Future Oncol; 2019 Mar; 15(7):791-800. PubMed ID: 30453756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma.
    Mirzaei H; Gholamin S; Shahidsales S; Sahebkar A; Jaafari MR; Mirzaei HR; Hassanian SM; Avan A
    Eur J Cancer; 2016 Jan; 53():25-32. PubMed ID: 26693896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.